|
Market Closed -
London S.E.
11:35:02 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.1550 GBX | 0.00% |
|
0.00% | -53.73% |
| 08-10 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 08-10 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALIRX PLC | Bio Therapeutic Drugs | 0.00% | 0.00% | -53.73% | -76.15% | -99.25% | 2.77M |  |  | |
- Stock Market
- Stocks
- VAL Stock
- Charts ValiRx plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
